Abbott Laboratories
Abbott
ABT · NYSE
Healthcare
Catalog as of September 15, 2026. Not a live market feed.
- Fiscal Year
- 2025
- Revenue
- $44.3B
- Assets
- $86.7B
- SEC filing
- DEF 14A
- Filed
- March 13, 2026
Executive Compensation
Compensation reported for Abbott’s named executive officers, including salary, stock awards, incentive compensation, other compensation, and total compensation.
Robert B. Ford
Chairman Of The Board And Chief Executive Officer
$24.2M
Reported total
- Salary
- $1,500,000
- Stock awards
- $8,787,378
- Incentives
- $1,968,750
- Option awards
- $8,788,430
- Other
- $3,154,102
Philip P. Boudreau
Executive Vice President, Finance And Chief Financial Officer
$9.1M
Reported total
- Salary
- $974,231
- Stock awards
- $3,045,935
- Incentives
- $1,055,400
- Option awards
- $3,046,350
- Other
- $968,720
Lisa D. Earnhardt
Executive Vice President And Group President, Medical Devices
$8.1M
Reported total
- Salary
- $924,231
- Stock awards
- $2,543,989
- Incentives
- $1,283,400
- Option awards
- $2,544,364
- Other
- $773,740
Hubert L. Allen
Former Executive Vice President, General Counsel And Secretary
$7M
Reported total
- Salary
- $524,019
- Stock awards
- $2,095,392
- Incentives
- $447,500
- Option awards
- $2,095,609
- Other
- $1,833,063
Christopher J. Scoggins
Executive Vice President, Diabetes Care
$6.6M
Reported total
- Salary
- $859,502
- Stock awards
- $1,662,503
- Incentives
- $1,095,300
- Option awards
- $1,662,743
- Other
- $1,321,619
Daniel G. Salvadori
Executive Vice President And Group President, Established Pharmaceuticals And Nutritional Products
$6.5M
Reported total
- Salary
- $924,231
- Stock awards
- $2,238,786
- Incentives
- $388,200
- Option awards
- $2,239,049
- Other
- $744,019
Robert B. Ford
Chairman Of The Board And Chief Executive Officer
$24.2M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A Summary Compensation Table, filed March 13, 2026.
- Salary
- $1.5M
- Stock Awards
- $8.8M
- Option Awards
- $8.8M
- Incentives
- $2M
- Other
- $3.2M
Historical Compensation
Robert B. Ford total compensation, fiscal years 2023–2025.
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $1,500,000 | $8,787,378 | $24,198,660 |
| 2024 | $1,500,000 | $8,226,593 | $22,777,075 |
| 2023 | $1,500,000 | $7,436,600 | $23,268,171 |
Named Executive Officers
Robert B. Ford
Chairman Of The Board And Chief Executive Officer
Abbott · ABT
$24.2M
FY 2025 · DEF 14A
Philip P. Boudreau
Executive Vice President, Finance And Chief Financial Officer
Abbott · ABT
$9.1M
FY 2025 · DEF 14A
Lisa D. Earnhardt
Executive Vice President And Group President, Medical Devices
Abbott · ABT
$8.1M
FY 2025 · DEF 14A
Daniel G. Salvadori
Executive Vice President And Group President, Established Pharmaceuticals And Nutritional Products
Abbott · ABT
$6.5M
FY 2025 · DEF 14A
Christopher J. Scoggins
Executive Vice President, Diabetes Care
Abbott · ABT
$6.6M
FY 2025 · DEF 14A
Hubert L. Allen
Former Executive Vice President, General Counsel And Secretary
Abbott · ABT
$7M
FY 2025 · DEF 14A
Source information
- Company
- Abbott Laboratories
- Ticker
- ABT · NYSE
- Filing type
- DEF 14A
- Fiscal year
- 2025
- Filing date
- March 13, 2026
- SEC accession number
- 0001308179-26-000064
Source: U.S. Securities and Exchange Commission, DEF 14A Summary Compensation Table. View SEC filing
Related Companies
Johnson & Johnson
JNJ · NYSE
Joaquin Duato
Chairman/CEO
$32.8M
FY 2025 reported total
View company →
UnitedHealth
UnitedHealth Group Incorporated
UNH · NYSE
Stephen Hemsley
Chief Executive Officer
$60.9M
FY 2025 reported total
View company →
AbbVie
AbbVie Inc.
ABBV · NYSE
Robert A. Michael
Chairman Of The Board And Chief Executive Officer
$32.5M
FY 2025 reported total
View company →
Align Technology
Align Technology Inc
ALGN · NASDAQ
Joseph M. Hogan
President And Chief Executive Officer
$19.2M
FY 2025 reported total
View company →